Including a subject-paced trial may make the PASAT more acceptable for MS patients.

O Bosnes1, O-P Dahl2, O Almkvist3,4

  • 1Department of Psychiatry, Namsos Hospital, Nord-Trøndelag Health Trust, Namsos, Norway.

Summary

A modified Paced Auditory Serial Addition Test (PASAT) better assesses cognitive function in multiple sclerosis (MS) patients. This subject-paced version improves user-friendliness without compromising the measurement of cognitive abilities.

Related Concept Videos